Lisa Tachiki

7PUBLICATIONS
12CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 10, 2025
From surgery to systemic therapy in von Hippel-Lindau disease: insights from extended follow-up of LITESPARK-004.

Lisa M Tachiki, Scott S Tykodi

|Aug 11, 2025
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade.

Lisa Tachiki, Yasman Moshiri, Daniel S Hippe

|Mar 18, 2025
Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients.

Emily Gong, Lauren Zawacki, Xinyi Fan

|Oct 14, 2024
Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses.

Thomas Pulliam, Saumya Jani, Peter H Goff

|Nov 18, 2023
Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma.

Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva

|Sep 21, 2023
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.

Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva

Pageof 2

Frequent Collaborators

4 joint publications

Shailender Bhatia

3 joint publications

Paul T Nghiem

2 joint publications

Thomas Pulliam

2 joint publications

Candice Church